Is Azilsartan More Effective in Younger Than in Older Patients? An Explorative Analysis of the Prospective EARLY Registry
- PMID: 26935989
- PMCID: PMC8032073
- DOI: 10.1111/jch.12804
Is Azilsartan More Effective in Younger Than in Older Patients? An Explorative Analysis of the Prospective EARLY Registry
Figures
Comment on
-
Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry.J Clin Hypertens (Greenwich). 2015 Dec;17(12):947-53. doi: 10.1111/jch.12603. Epub 2015 Jun 24. J Clin Hypertens (Greenwich). 2015. PMID: 26105590 Free PMC article.
-
Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?J Clin Hypertens (Greenwich). 2016 Aug;18(8):828. doi: 10.1111/jch.12809. Epub 2016 Mar 3. J Clin Hypertens (Greenwich). 2016. PMID: 26936105 Free PMC article. No abstract available.
References
-
- Schmieder RE, Potthoff SA, Bramlage P, et al. Patients with newly diagnosed hypertension treated with the renin angiotensin receptor blocker azilsartan medoxomil vs angiotensin‐converting enzyme inhibitors: the prospective EARLY registry. J Clin Hypertens (Greenwich). 2015;17:947–953. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
